HELZ2
3'-5' exoribonuclease HELZ2
Also known as: HELZ2_HUMAN, KIAA1769, PDIP1, PRIC285
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYK8
- Gene
- HELZ2
- Ensembl
- ENSG00000130589
- Chromosome
- 20
- Canonical length
- 2896 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a nuclear transcriptional co-activator for peroxisome proliferator activated receptor alpha. The encoded protein contains a zinc finger and is a helicase that appears to be part of the peroxisome proliferator activated receptor alpha interacting complex. This gene is a member of the DNA2/NAM7 helicase gene family. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
2896 residues, UniProt reviewed canonical sequence.
>Q9BYK8|HELZ2
1 MAPPGSTLLP NSPAATRGPS LARLCALVDL CLGCSRCTQR LNESTYVLRR VEHDCSREIL
61 LARFKQATKS KVWRVVGCRP TFPRPLCYQV CHYYSPGLGC RRHRNRCTFA RSREEALVWT
121 FERQHNLQRL WLKAEVQGSG AQGGAGRAAD AILTEFGGRF ELLCSLCFRR CPPCICRVDP
181 QGQCPEHGAC PSLLAHVSAE GRRKQQFVVV RPRPRAGQPP AYCRFVGRGQ PCWRGESRCQ
241 FAHSAVEMAV WEAEQLGGLQ RGDLLTPPAP DGDGRTAPLG QPPGAQLYCP ACLVTCHSQE
301 AFENHCASSE HAQMVAFDQA LPWEHRSPPP GLSKFELCPK PDLCEYGDAC TKAHSAQELQ
361 EWVRRTQAVE LRGQAAWQDG LVPYQERLLA EYQRSSSEVL VLAETLDGVR VTCNQPLMYQ
421 AQERKTQYSW TFAVHSEEPL LHVALLKQEP GADFSLVAPG LPPGRLYARG ERFRVPSSTA
481 DFQVGVRVQA ASFGTFEQWV VFDFGRRPVL LQKLGLQLGQ GRRPGPCRNL ALGHPEEMER
541 WHTGNRHVVP GVERTAEQTA LMAKYKGPAL ALEFNRSSVA SGPISPTNYR QRMHQFLYEE
601 EAAQQQLVAK LTLRGQVFLK TALQTPALNM LFAPPGALYA EVPVPSSLMP DTDQGFLLGR
661 AVSTALVAPV PAPDNTVFEV RLERRASSEQ ALWLLLPARC CLALGLQPEA RLVLEVQFQI
721 DPMTFRLWHQ AVDTLPEEQL VVPDLPTCAL PRPWSVPPLR RGNRKQELAV ALIAGWGPGD
781 GRRVPPLLIY GPFGTGKTYT LAMASLEVIR RPETKVLICT HTNSAADIYI REYFHSHVSG
841 GHPEATPLRV MYTDRPLSQT DPVTLQYCCL TDDRQAFRPP TRAELARHRV VVTTTSQARE
901 LRVPVGFFSH ILIDEAAQML ECEALTPLAY ASHGTRLVLA GDHMQVTPRL FSVARARAAE
961 HTLLHRLFLC YQQETHEVAR QSRLVFHENY RCTDAIVSFI SRHFYVAKGN PIHARGKVPP
1021 HPRHYPLMFC HVAGSPDRDM SMASWLNLAE IAQVVEKVQE AYNTWPSCWG GREQRCICVV
1081 SHGAQVSALR QELRRRDLGQ VSVGSFEILP GRQFRVVVLS TVHTCQSLLS PGALAPEFFT
1141 DARVLNTVLT RAQSQLVVVG DAVALCSFGA CGKLWESFIR ECVERHSVCP EGLSMEQVEQ
1201 GVAQRRRWPP RGTQAGAAGN WEAAPEPVGD LAEEQAAVVT AMVKAEPGDE ALSPASRDIT
1261 ATTAQTEAAA APAGDAVKED VVPGACAAGA AAAAGVESTE AEDAEADFWP WDGELNADDA
1321 ILRELLDESQ KVMVTVGEDG LLDTVARPES LQQARLYENL PPAALRKLLH AEPERYRHCS
1381 FVPETFERAS AIPLDDASSG PIQVRGRLDC GMAFAGDEVL VQLLSGDKAP EGRLRGRVLG
1441 VLKRKRHELA FVCRMDTWDP RIMVPINGSV TKIFVAELKD PSQVPIYSLR KGRLQRVGLE
1501 RLTAEARHSR LFWVQIVLWR QGFYYPLGIV REVLPEASTW EQGLRILGLE YSLRVPPSDQ
1561 ATITKVLQKY HTELGRVAGR REDCRAFLTF TVDPQGACNL DDALSVRDLG PRCEVAVHIT
1621 DVASFVPRDG VLDVEARRQG AAFYAPGREP VPMLPASLCQ DVLSLLPGRD RLAISLFLTM
1681 EKASGQLKSL RFAPSVVQSD RQLSYEEAEE VIRQHPGAGR ELPARLDSVD ACVVAACYFS
1741 RLLRRHRLRS DCFYEQPDED GTLGFRAAHI MVKEYMIQFN RLVAEFLVGS ECTRTVTPLR
1801 WQPAPRSQQL KALCEKHGDR VPLSLHLGHH LHGGGGSPPD TRLHLLASLW KQVQFAARTQ
1861 DYEQMVDLVT TDDMHPFLAP AGRDLRKALE RSAFGRCARG HQQQGGHYSL QVDWYTWATS
1921 PIRRYLDVVL QRQILLALGH GGSAYSARDI DGLCQAFSLQ HALAQSYQRR ARSLHLAVQL
1981 KAQPLDKLGF VVDVEAGSRC FRLLFPSNRE TLPDPCPVPY GSLQLAEHPH ALAGRPGLRL
2041 LWRRRVYSAQ GSSPPLPLPG TVPDPHTLAV ETALWKQLLE LVELQRWPEA AALIQEKGEA
2101 SQRRELVQVQ RSHCGHFLEV ARELGSGDTL QVQLGTSLQH GFLVPSPQLW TVAPGFSLCL
2161 EHVERPGDCF SGRVYRAPRD RYRDVDEYAC VWEPFCALES ATGAVAENDS VTLQHLSVSW
2221 EASRTPQGQL QGAFRLEAAF LEENCADINF SCCYLCIRLE GLPAPTASPR PGPSSLGPGL
2281 NVDPGTYTWV AHGQTQDWDQ ERRADRQEAP RRVHLFVHHM GMEKVPEEVL RPGTLFTVEL
2341 LPKQLPDLRK EEAVRGLEEA SPLVTSIALG RPVPQPLCRV IPSRFLERQT YNIPGGRHKL
2401 NPSQNVAVRE ALEKPFTVIQ GPPGTGKTIV GLHIVFWFHK SNQEQVQPGG PPRGEKRLGG
2461 PCILYCGPSN KSVDVLAGLL LRRMELKPLR VYSEQAEASE FPVPRVGSRK LLRKSPREGR
2521 PNQSLRSITL HHRIRQAPNP YSSEIKAFDT RLQRGELFSR EDLVWYKKVL WEARKFELDR
2581 HEVILCTCSC AASASLKILD VRQILVDEAG MATEPETLIP LVQFPQAEKV VLLGDHKQLR
2641 PVVKNERLQN LGLDRSLFER YHEDAHMLDT QYRMHEGICA FPSVAFYKSK LKTWQGLRRP
2701 PSVLGHAGKE SCPVIFGHVQ GHERSLLVST DEGNENSKAN LEEVAEVVRI TKQLTLGRTV
2761 EPQDIAVLTP YNAQASEISK ALRREGIAGV AVSSITKSQG SEWRYVLVST VRTCAKSDLD
2821 QRPTKSWLKK FLGFVVDPNQ VNVAVTRAQE GLCLIGDHLL LRCCPLWRSL LDFCEAQQTL
2881 VPAGQVRVCR RPTMPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HELZ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 14 nTPM
- spleen: 12 nTPM
- salivary gland: 10 nTPM
- lung: 9.5 nTPM
- liver: 7.3 nTPM
- stomach: 7.2 nTPM
Single-cell type
- esophageal apical cells: 77 nCPM
- neutrophils: 58 nCPM
- esophageal suprabasal cells: 41 nCPM
- foveolar cells: 31 nCPM
- urothelial cells: 29 nCPM
- neutrophil progenitors: 27 nCPM
Immune cell
- eosinophil: 0.4 nTPM
- neutrophil: 0.4 nTPM
- total PBMC: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- medulla oblongata: 13 nTPM
- spinal cord: 13 nTPM
- thalamus: 9.7 nTPM
- pons: 8.6 nTPM
- amygdala: 8.2 nTPM
- midbrain: 6.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription by RNA polymerase II
- regulatory ncRNA-mediated post-transcriptional gene silencing
Molecular functions
- ATP binding
- ATP hydrolysis activity
- DNA binding
- exoribonuclease II activity
- RNA binding
- RNA helicase activity
- transcription coactivator activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, CCCH-type
- Ribonuclease II/R
- Nucleic acid-binding, OB-fold
- Ribonuclease II/R, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- Zinc finger C2H2 superfamily
- DNA2/NAM7 helicase, helicase domain
- DNA2/NAM7 helicase-like, C-terminal
- Upf1-like, C-terminal helicase domain
- Coronaviruses polyprotein 1ab
- RNB domain
- AAA domain
- AAA domain
- 3'-5' exoribonuclease HELZ2, OB-fold domain
- 3'-5' exoribonuclease HELZ2, OB-fold domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HELZ2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HELZ2 as an antibody target. Whether an autoantibody or antibody against HELZ2 could matter depends on whether native HELZ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HELZ2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HELZ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...